CH-223191 Mechanism of Action: AhR Inhibition in T Cell Research

CH-223191 MOA:Targeting AhR/Kynurenine Pathway for Tumor Immunology

🎯 check CH-223191 product page

CH-223191 is a potent, selective aryl hydrocarbon receptor (AhR) antagonist. It blocks AhR signaling by preventing ligand-induced nuclear translocation and DNA binding, effectively inhibiting TCDD-induced CYP1A1 expression and Th17 cell differentiation.

Primary Applications and Mechanism of Action